February 1, 2018 / 4:41 PM / 5 months ago

BRIEF-Roche Drugs Chief Says Erosion In European Rituxan Sales To Intensify In 2018 As Biosimilars Enter More Markets After 26 Percent 4th Quarter Drop

Feb 1 (Reuters) - Roche:

* DRUGS CHIEF SAYS EROSION IN EUROPEAN RITUXAN SALES TO INTENSIFY IN 2018 AS BIOSIMILARS ENTER MORE MARKETS AFTER 26 PERCENT 4TH QUARTER DROP Source text for Eikon: Further company coverage: (Reporting by John Miller)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below